The term pulse therapy refers to discontinuous intravenous infusion of
very high doses of drugs over a short time. Methylprednisolone (and d
examethasone in some countries) is the glucocorticoid most frequently
administered this way. Doses of each pulse are not standardized but ar
e usually 10 to 20 mg per kilogram of body weight for methylprednisolo
ne (250-1000 mg) and 2 to 5 mg per kilogram of body weight (50-200 mg)
for dexamethasone. Single doses of 500 mg of methylprednisolone and 1
00 mg of dexamethasone are both considered equivalent to 625 mg of pre
dnisone.(1) These very high doses, sometimes termed megadoses, are usu
ally given as intravenous infusions over 30 minutes to 1 hour daily or
every other day for a total of 1 to 5 administrations. In most indica
tions, pulse glucocorticoid therapy is accompanied and/or followed by
the continuous administration of low- or intermediate-dose glucocortic
oids and/or immunosuppressive agents.